Course Goals and Objectives

The goal of this EQIPP course is to apply the Bright Futures Guidelines, 4th Edition, core materials, strategies, and tools to promote and improve the health and well-being of patients and their families. 

Objectives

By the end of this course, you will be able to apply knowledge from Bright Futures Guidelines, 4th Edition, core materials and other AAP endorsed guidelines, policy statements, technical reports, and recommendations for the health supervision of all children to do the following:

• Elicit and address patient/family interests and concerns.
• Identify and discuss patient/family strengths.
• Assess and address social determinants (drivers) of health (SDOH) that emerge from the family’s and community’s circumstances, and which affect health in positive and negative ways.
• Provide age-appropriate health promotion and disease prevention anticipatory guidance centered on the Bright Futures health supervision visit priorities.
• Perform perinatal depression screening at recommended health supervision visits and follow up on positive screens.
• Perform developmental screening or surveillance at all health supervision visits and follow up on positive screens.
• Assess growth/weight  at all health supervision visits and follow up on growth/weight concerns. 
• Verify immunization status at all health supervision visits and address missed immunizations.
• Perform oral health risk assessment that includes recommendation to a dental home, fluoride application, and follow up on positive assessments.
• Perform autism spectrum disorder-specific screening at 18 months and 2 years and follow up on positive screens.
• Perform age-appropriate risk assessment at all health supervision visits and follow up on positive assessments.
• Perform behavioral-social-emotional assessment at all health supervision visits and follow up on positive screens.
• Perform lipid screening for patients between ages 9–11 years and follow up on positive screens.
• Perform annual substance use screening for patients ages 11–21 years (more often as needs arise) and follow up on positive screens.
• Perform adolescent depression and suicide risk screening for patients ages 12–21 years and follow up on positive screens.
• Perform HIV screening at least once for patients ages 15–18 years (more often if risk factors are present) and follow up on positive screens.

Perform chlamydia screening annually for patients ages 11–21 years who are female and sexually active, are male who are sexually active and at increased risk, and follow up on positive screens.